| COVID-19 among patients with multiple sclerosis: a systematic review M Barzegar, O Mirmosayyeb, M Gajarzadeh, A Afshari-Safavi, N Nehzat, ... Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1001, 2021 | 89 | 2021 |
| COVID-19 infection in a patient with multiple sclerosis treated with fingolimod M Barzegar, O Mirmosayyeb, N Nehzat, R Sarrafi, F Khorvash, AH Maghzi, ... Neurology: Neuroimmunology & Neuroinflammation 7 (4), e753, 2020 | 82 | 2020 |
| Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis O Mirmosayyeb, S Brand, M Barzegar, A Afshari-Safavi, N Nehzat, ... Journal of clinical medicine 9 (5), 1326, 2020 | 77 | 2020 |
| Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study M Barzegar, S Vaheb, O Mirmosayyeb, A Afshari-Safavi, N Nehzat, ... Multiple sclerosis and related disorders 52, 102947, 2021 | 59 | 2021 |
| Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran M Barzegar, S Badihian, O Mirmosayyeb, F Ashtari, M Jamadi, S Emami, ... Multiple sclerosis and related disorders 22, 161-165, 2018 | 57 | 2018 |
| The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis AN Moghadasi, O Mirmosayyeb, M Barzegar, MA Sahraian, ... Neurological sciences 42 (8), 3093-3099, 2021 | 46 | 2021 |
| An 8-year study of people with multiple sclerosis in Isfahan, Iran: Association between environmental air pollutants and severity of disease F Ashtari, N Esmaeil, M Mansourian, P Poursafa, O Mirmosayyeb, ... Journal of neuroimmunology 319, 106-111, 2018 | 42 | 2018 |
| Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic M Ghajarzadeh, O Mirmosayyeb, M Barzegar, N Nehzat, S Vaheb, ... Multiple Sclerosis and Related Disorders 43, 102222, 2020 | 35 | 2020 |
| Characteristics of COVID-19 disease in multiple sclerosis patients M Barzegar, O Mirmosayyeb, M Ghajarzadeh, N Nehzat, S Vaheb, ... Multiple Sclerosis and Related Disorders 45, 102276, 2020 | 33 | 2020 |
| Early predictors of conversion to secondary progressive multiple sclerosis M Barzegar, S Najdaghi, A Afshari-Safavi, N Nehzat, O Mirmosayyeb, ... Multiple sclerosis and related disorders 54, 103115, 2021 | 30 | 2021 |
| The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis O Mirmosayyeb, M Barzegar, N Nehzat, V Shaygannejad, MA Sahraian, ... Journal of Clinical Neuroscience 79, 33-38, 2020 | 27 | 2020 |
| Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review O Mirmosayyeb, EM Ghaffary, S Bagherieh, M Barzegar, MS Dehghan, ... Multiple Sclerosis and Related Disorders 60, 103697, 2022 | 22 | 2022 |
| COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis M Barzegar, O Mirmosayyeb, N Ebrahimi, S Bagherieh, A Afshari-Safavi, ... Multiple Sclerosis and Related Disorders 57, 103359, 2022 | 21 | 2022 |
| Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls M Barzegar, DS Bahmani, N Nehzat, M Kiani, N Hashemi, O Mirmosayyeb, ... Multiple sclerosis and related disorders 32, 81-87, 2019 | 19 | 2019 |
| Frequency of comorbidities in Neuromyelitis Optica spectrum disorder M Barzegar, O Mirmosayyeb, N Nehzat, S Vaheb, V Shaygannejad, ... Multiple Sclerosis and Related Disorders 48, 102685, 2021 | 16 | 2021 |
| Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study F Ashtari, A Ataei, R Kafieh, Z Khodabandeh, M Barzegar, M Raei, ... Multiple Sclerosis and Related Disorders 47, 102625, 2021 | 16 | 2021 |
| Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis O Mirmosayyeb, N Ebrahimi, A Shekarian, A Afshari-Safavi, ... Journal of Clinical Neuroscience 108, 84-94, 2023 | 15 | 2023 |
| Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination O Mirmosayyeb, M Barzegar, M Rezaei, N Baharlouie, V Shaygannejad Clinical case reports 10 (2), e05468, 2022 | 14 | 2022 |
| Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis M Barzegar, S Houshi, E Sadeghi, MS Hashemi, G Pishgahi, S Bagherieh, ... | 12 | 2022 |
| Screening neuromyelitis optica patients for COVID-19 infection O Mirmosayyeb, S Vaheb, M Barzegar, V Shaygannejad, S Bonavita, ... Autoimmunity Reviews 19 (11), 102669, 2020 | 12 | 2020 |
Omid Mirmosayyeb, MDDepartment of Neurology, Jacobs School of Medicine and Biomedical Sciences, University of BuffaloVerified email at buffalo.edu
